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Caenorhabditis elegans N-glycan core beta-galactoside confers
sensitivity towards nematotoxic fungal galectin CGL2
Abstract
The physiological role of fungal galectins has remained elusive. Here, we show that feeding of a
mushroom galectin, Coprinopsis cinerea CGL2, to Caenorhabditis elegans inhibited development and
reproduction and ultimately resulted in killing of this nematode. The lack of toxicity of a
carbohydrate-binding defective CGL2 variant and the resistance of a C. elegans mutant defective in
GDP-fucose biosynthesis suggested that CGL2-mediated nematotoxicity depends on the interaction
between the galectin and a fucose-containing glycoconjugate. A screen for CGL2-resistant worm
mutants identified this glycoconjugate as a Galbeta1,4Fucalpha1,6 modification of C. elegans N-glycan
cores. Analysis of N-glycan structures in wild type and CGL2-resistant nematodes confirmed this
finding and allowed the identification of a novel putative glycosyltransferase required for the
biosynthesis of this glycoepitope. The X-ray crystal structure of a complex between CGL2 and the
Galbeta1,4Fucalpha1,6GlcNAc trisaccharide at 1.5 A resolution revealed the biophysical basis for this
interaction. Our results suggest that fungal galectins play a role in the defense of fungi against predators
by binding to specific glycoconjugates of these organisms.
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nematode. The lack of toxicity of a carbohydrate-binding defective CGL2 variant and the resistance of a C. elegans mutant
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biosynthesis of this glycoepitope. The X-ray crystal structure of a complex between CGL2 and the Galb1,4Fuca1,6GlcNAc
trisaccharide at 1.5 A˚ resolution revealed the biophysical basis for this interaction. Our results suggest that fungal galectins play
a role in the defense of fungi against predators by binding to specific glycoconjugates of these organisms.
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Introduction
Lectins are defined as non-immunoglobulin, carbohydrate-
binding proteins without catalytic activity towards the recognized
carbohydrate [1]. They occur in all domains of life and are very
diverse with respect to structure, carbohydrate-binding specificity
and function [2]. Specific lectins play an important role in the
defense against predators, parasites and pathogens due to their
ability to recognize specific carbohydrate signatures displayed on
the cell surfaces of these organisms. They act either as direct
effectors or as opsonins, i.e., by recruiting other effectors of the
immune system. Examples of the former type are bacterial toxins
directed against bacterivores (Bacillus thuringiensis crystal toxins),
plant lectins directed against herbivores (Ricinus communis (Ricin)
toxin), and mammalian lectins directed against bacterial and
fungal mucosal pathogens (RegIIIc [3] and galectin-3 [4],
respectively). The effector role of all these lectins is based on their
toxicity towards the predator or pathogen. In only a few cases is
the molecular basis of this toxicity known in terms of identification
of the target glycoconjugate in the predator/pathogen recognized
by the lectin. For example, the nematicidal crystal toxin Cry5B
from B. thuringiensis was shown to bind a specific glycosphingolipid
on the intestinal epithelium of the bacterivorous nematode
Caenorhabditis elegans [5] and antifungal mammalian galectin-3
was shown to bind b1,2-linked mannans on the surface of Candida
albicans cells [4]. It should be noted here that Ricin and many
bacterial toxins contain additional domains with pore-forming or
catalytic activity which contribute to the toxicity of these lectins
[6].
Fungal fruiting-bodies are a rich source for lectins of various
structures and specificities [7,8,9,10]. A specific subgroup of fungal
lectins, the so-called fruiting-body lectins, are characterized by
their specific expression and abundance in the fruiting body and
their cytoplasmic subcellular localization. The latter property is
concluded from the absence of a signal peptide for classical
secretion and the concomitant lack of disulphide bridges or protein
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glycosylation. The physiological function of these fruiting body
lectins, however, remains unknown. A suggested role in fruiting
body formation, based on the developmental regulation of their
expression, has become unlikely based on recent studies in the
ascomycete (sac fungus) Sordaria macrospora and the homobasidio-
mycete (mushroom) Coprinopsis cinerea [11,12]. Given the frequent
role of lectins in defense of other organisms and the reported
toxicity of fruiting-body lectins towards insects and mammalian
cells [13,14,15,16,17,18,19], we and others hypothesized that this
group of lectins may be effectors of a fungal defense system against
fungivores. Examples for predators that have specialized on fungi
as food source are larvae of some flies and fungal-feeding
nematodes [20,21,22]. In comparison to insects, fungal-feeding
nematodes represent, due to their high number in soil and any
kind of decaying organic matter, a major threat to fungi in their
ecological environment [23,24].
The fungus C. cinerea expresses several fruiting body lectins
including two isogalectins, CGL1 and CGL2, and a galectin-
related lectin, CGL3 [25,26,27]. In agreement with above
hypothesis, we demonstrate that both C. cinerea isogalectins
displayed toxicity towards the model soil nematode C. elegans.
Based on a number of approaches, including the use of E. coli
expressing these fungal lectins to mimic the in vivo situation, we
conclude that this nematotoxicity is dependent on the specific
interaction between these proteins and a b-galactoside on the core
of N-glycans in the C. elegans intestine.
Results
CGL2 inhibits C. elegans development and reproduction
dependent on its carbohydrate-binding ability
To test the C. cinerea galectins for nematotoxic activity in a
genetically tractable system, the bacterivorous model nematode C.
elegans was fed with E. coli cells expressing either the authentic
CGL1 and CGL2 proteins or the carbohydrate-binding defective
variant CGL2(W72G) in the cytoplasm in comparison to ‘empty
vector’-containing E. coli transformants. The essential role of W72
in the coordination of b-galactosides by CGL2 was demonstrated
previously [28]. For CGL2 and CGL2(W72G), the effect of this
diet on C. elegans development, reproduction and survival was
examined by determining the fraction of L1 larvae developing to
the L4 stage within 72 h, the brood size per hermaphrodite and
the survival of L4 larvae, respectively. The results of all three
assays showed a strong effect of the fungal galectin, i.e., the
animals that fed on CGL2-expressing bacteria were severely
inhibited in larval development and showed a reduced brood size
and survival (Fig. 1, panels A to C). The nematotoxicity was
dependent on the ability of CGL2 to bind carbohydrates since the
CGL2(W72G) variant, which does not possess b-galactoside
binding activity [28], did not show any effect in either assay. For
CGL1, only larval development was scored, yielding similar results
as in the case of CGL2 (Fig. 1A, left panel).
The effect of using bacteria expressing CGL2 was verified using
the purified recombinant lectin. Incubation of L1 larvae with
different concentrations of purified CGL2 with empty vector-
containing bacteria demonstrated that the lectin-mediated arrest
in larval development was dose-dependent with a median lethal
dose (LD50) of approximately 350 mg/ml (Fig. 1, panel A right).
Comparative light- and electron-microscopy of C. elegans L4 larvae
fed with CGL2-expressing or empty vector-containing E. coli cells
revealed that the lumen of the anterior intestine was expanded in
the former animals and that the microvillar ultrastructure of the
epithelium was damaged (Fig. 1, panel D). These results
demonstrated that the C. cinerea galectin CGL2 had a pronounced
nematotoxic activity that was dependent on the ability of the
protein to bind carbohydrates.
The CGL2-ligand in C. elegans is different from the
Cry5B-ligand but its biosynthesis also relies on fucose
biosynthesis
The phenotype of CGL2-mediated nematotoxicity was remi-
niscent of the intoxication of C. elegans induced by feeding with E.
coli cells expressing the nematicidal pore-forming crystal toxin
Cry5B from Bacillus thuringiensis [29]. Indicative of the role of
carbohydrate binding in their function, crystal toxins contain lectin
domains that are necessary for toxicity [30] and indeed a genetic
screen for Cry5B-resistant C. elegans mutants yielded mutations in
five different genes, bre-1(ye4), bre-2(ye31), bre-3(ye26), bre-4(ye27)
and bre-5(ye17) [29]. Four of these C. elegans genes code for
glycosyltransferases involved in the biosynthesis of a specific, b-
galactoside-containing glycosphingolipid (bre-2 to bre-5) and one
gene encodes an enzyme involved in the conversion of GDP-
mannose into GDP-fucose (bre-1) [31]. Given the specificity of C.
cinerea galectins for b-galactoside-containing oligosaccharides
[27,28], we tested each bre mutant for resistance to CGL2.
Unexpectedly, we found that the bre-1 mutation conferred almost
complete resistance whereas the other bre mutants, with the
exception of the bre-4 mutant, that was as sensitive as wild type C.
elegans, appeared even more sensitive to CGL2 than wild type
(Fig. 2). The bre-1(ye4) mutant also showed resistance towards
CGL1-mediated nematotoxicity suggesting that CGL1 acts via the
same mechanism (data not shown). These results demonstrated
that the ligand of C. cinerea galectins in C. elegans was different from
the Cry5B-ligand but that its biosynthesis relied on fucose
biosynthesis as in the case of the bacterial toxin.
Mutations in the C. elegans p38 MAPK pathway cause
hypersensitivity to CGL2
Based on the resistance of the C. elegans bre-1(ye4) mutant
towards feeding of CGL2-expressing bacteria we initiated a
Author Summary
Fungi are a source of a large variety of carbohydrate-
binding proteins (lectins). Synthesis of these proteins
usually occurs in the cytoplasm and is often restricted to
the reproductive organs (fruiting bodies, sclerotia) of the
respective fungi. Although these lectins can be very
abundant in these organs, their function is unknown.
The specificity for non-fungal carbohydrates and recent
functional studies in genetically amenable fungi argue
against an endogenous function in development. Here we
show that oral administration of the fruiting-body-specific
galectins of the ink cap mushroom Coprinopsis cinerea is
toxic for the model nematode Caenorhabditis elegans and
that the nematotoxicity of these fungal lectins is depen-
dent on binding to a specific b-galactoside occurring on
nematode, but not on fungal, N-glycans. Since fungal-
feeding nematodes represent the predominant predators
of fungi in the soil, these results suggest that these lectins
are effectors of a protein-mediated fungal defense system.
Lectin-mediated defense strategies against predators,
parasites and pathogens are also used by plants and
animals. Due to the conservation of this type of innate
defense amongst eukaryotes and the reduced complexity
of fungi, studies of this in fungi could contribute to a
better understanding of analogous systems and the
evolution of multi-level defense in animals.
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Figure 1. Dose and carbohydrate-binding dependent toxicity of C. cinerea galectin CGL2 towards C. elegans. In all of the experiments, E.
coli BL21(DE3) cells expressing either the authentic CGL1 or CGL2 proteins or the carbohydrate-binding defective variant CGL2(W72G), or control
transformants were fed to C. elegans wild type N2. (A) CGL2 inhibits C. elegans development. C. elegans L1 larvae were seeded onto lawns of above
bacteria (left panel) or fed with increasing concentrations of purified CGL2 together with equal amounts of empty vector-containing BL21(DE3) in
liquid culture (right panel) and scored for the fraction developing to the L4 stage within 72 h and 96 h, respectively. Columns represent the average
of 6 and 12 replicates, respectively. Error bars indicate standard deviations. The fraction of animals reaching L4 was significantly lower on CGL1- or
CGL2-expressing bacteria (p,0.01) than on bacteria expressing CGL2(W72G) or containing empty vector. No significant difference was observed
between latter two conditions (p.0.5). In the liquid assay, worm development decreases significantly at CGL2 concentrations higher than 150 mg/ml.
(B) CGL2 inhibits C. elegans reproduction. C. elegans hermaphrodites were placed as L4 animals on plates seeded with above bacteria and scored for
total progeny counts per hermaphrodite. The broods of eight to ten hermaphrodites were averaged per data point. The standard deviations are
indicated. The differences between the L4 fractions on CGL2 and vector control and CGL2(W72G) were statistically significant (p.0.01). None of the
progeny on wild type CGL2 developed to adulthood within 96 h post hatch. (C) CGL2 ultimately kills C. elegans. 10 L4 staged wild type C. elegans (N2)
were seeded onto lawns of CGL2-, CGL2(W72G)-expressing and empty vector control-containing E. coli BL21(DE3) cells. Each day, the plates were
checked for surviving animals which were then transferred to novel bacterial lawns of the same type. The data points represent the average of five
replicates. Error bars indicate standard deviations. The survival rate of the worms was significantly impaired on CGL2-expressing bacteria compared to
CGL2(W72G) and vector control (p,0.01), whereas there was no significant difference between latter two conditions (p.0.5). (D) CGL2 damages C.
elegans intestine. C. elegans L4 larvae were fed with CGL2-expressing (panels i-vi) and control E. coli BL21(DE3) cells (panels i-iii) and examined after
24 h under the stereomicroscope (panels i,iv), by differential interference contrast (DIC) microscopy (panels ii, v) and by transmission electron
microscopy (TEM) (panels iii,vi). The size bars in panels iii and vi are 200 nm.
doi:10.1371/journal.ppat.1000717.g001
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forward genetic screen for mutations conferring CGL2-resistance
in order to identify the target glycoconjugate of CGL2 in C. elegans.
For an efficient selection of CGL2-resistant mutants, it was
essential to lower the background of 10% surviving worms in case
of C. elegans wild type strain (N2) (Fig. 4, panel A). Since mutants in
the p38 mitogen-activated protein kinase (MAPK) pathway of C.
elegans were previously shown to be hypersensitive towards
pathogenic bacteria and Cry5B-expressing E. coli cells [32,33],
we tested whether these strains would also be more susceptible
towards feeding with the CGL2-expressing E. coli cells. For this
purpose, L4 larvae derived from N2 wild type and isogenic pmk-
1(km25) (p38 MAPK), sek-1(ag1) (MAPK kinase) and nsy-1(ag3)
(MAPK kinase kinase) mutant worms were tested for survival on a
lawn of CGL2-expressing bacteria over time. We found that all of
the mutations increased the sensitivity of C. elegans towards the
fungal galectin but that the effect of the pmk-1 mutation was most
pronounced (Fig. 3, panel A). As a proof of principle for the
subsequent screen, we constructed a worm carrying the bre-1(ye4)
mutation in a pmk-1(km25) mutant genetic background and tested
this strain for its sensitivity to CGL2 in comparison to the pmk-
1(km25) single mutant strain. The double mutant strain exhibited
significant resistance towards CGL2 confirming the previous
results in the wild type background and suggesting that a forward
genetic screen for mutations conferring CGL2-resistance in a pmk-
1(km25) mutant genetic background was feasible (Fig. 4, panel A).
The screen, as outlined in Fig. 3 (panel B), was based on an
insertional mutagenesis using the Mos1 transposon to facilitate the
identification of the obtained mutations.
Mutations affecting a1,6-core fucosylation of C. elegans
N-glycans confer resistance to CGL2 and prevent binding
of CGL2 to the intestine
The screen yielded Mos1-insertions in five different genes: bre-1,
ger-1, gly-13, fut-8 and M03F8.4. The degree of resistance towards
CGL2-intoxication was determined for each of the outcrossed
mutants and is shown in Fig. 4 (panel A). The identified Mos1-
insertions are located in 59-untranslated regions (bre-1(op509)), at
an exon-intron junction (gly-13(op507)) and in exons (ger-1(op499),
fut-8(op498) and M03F8.4(op497)), respectively (Fig. 3, panel D).
bre-1 and ger-1 code for the GDP-mannose-4,6-dehydratase and
GDP-4-keto-6-deoxymannose-3,5-epimerase-4-reductase, respec-
tively, catalyzing the two enzymatic steps in the conversion from
GDP-mannose to GDP-fucose [34]. The link between the
biosynthesis of GDP-fucose and the biosynthesis of a specific
glycoconjugate was offered by the data indicating a role for the fut-
8 and gly-13 genes in toxicity, suggesting that N-glycans are the
targets of CGL2. The fut-8 gene encodes the only fucosyltransfer-
ase capable of transferring fucose in a1,6-configuration from
GDP-fucose to the asparagine-linked GlcNAc in C. elegans N-
glycan cores [35], whereas the gly-13 gene codes for the major
GlcNAc-transferase I (GnTI) in C. elegans [36], which transfers
GlcNAc in b1,2-configuration to the a1,3-linked mannose of
pentamannosidic N-glycan. The modification of N-glycans by
GnTI is the prerequisite for many of the subsequent modifications
of N-glycans including the action of core a1,6-fucosyltransferase
[37]; on the other hand, GnTI is not required in C. elegans for the
core modification by another fucosyltransferase, encoded by the
fut-1 gene, which forms the so-called HRP epitope consisting of
fucose a1,3-linked to the core asparagine-linked GlcNAc [38].
In order to confirm and corroborate these data, two available
mutations affecting both types of core fucosylation, fut-8(ok2558)
and fut-1(ok892), were each crossed into the pmk-1 mutant
background and the resulting double mutants were tested for
CGL2-sensitivity. In agreement with the results of the forward
genetic screen, the fut-8(ok2558) mutation conferred clear
resistance towards CGL2, recapitulating the phenotype shown
by the fut-8(op498) allele, whereas the fut-1 pmk-1 double mutant
was as susceptible as the pmk-1 single mutant (Fig. 4, panel A).
Analogous tests for CGL1-sensitivity yielded similar results
providing additional evidence that CGL1 and CGL2 confer
nematotoxicity via the same mechanism (data not shown).
In addition, available mutants of all other characterized C.
elegans fucosyltransferase (fut)- and N-acetylglucosaminyltransferase
(gly)-encoding genes were tested for CGL2-sensitivity in compar-
ison to wild type N2 worms. With exception of fut-8(ok2558) and
gly-13(ok712) and consistent with the putative biosynthetic roles of
the relevant genes, none of the tested mutations conferred
resistance in this background suggesting that the effects of the
mutations identified in the screen were highly specific (Fig. 5). In
the case of gly-13, the tested strain background carried a mutation
in an additional gene, dpy-6, that is required for normal body
Figure 2. Resistance of bre-1 mutant towards CGL2-mediated toxicity. L1 larvae of C. elegans bre-1 to bre-5 mutant strains as well as wild-
type N2 were seeded onto a lawn of CGL2-expressing E. coli BL21(DE3) cells and scored for the fraction developing to the L4 stage within 72 h.
Columns represent the average of 6 replicates. Error bars indicate standard deviations. The fraction of animals reaching L4 was significantly higher for
the bre-1 mutant (p,0.01) than for the wild type (N2) or the bre-4 mutant. No significant difference was observed between latter two strains (p.0.5).
For the rest of the mutants, not a single larva developed, so results were not compared statistically.
doi:10.1371/journal.ppat.1000717.g002
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Figure 3. Workflow of the forward genetic screen for CGL2-resistant C. elegans mutants. (A) CGL2-sensitivity test of pmk-1, sek-1 and nsy-1
mutant worms defective in the p38 MAPK pathway. 10 L4 staged worms of the indicated genotypes were seeded onto a lawn of CGL2-expressing E. coli
BL21(DE3) cells. The plates were checked for surviving animals at the indicated time points. The data points represent the average of ten replicates. Error
bars indicate standard deviations. The pmk-1 and sek-1 mutants were significantly hypersensitive compared to the N2 wild type strain (p,0.01), whereas
the slightly higher sensitivity of the nsy-1 mutant is less significant (p,0.2). (B) Mos1 insertional mutagenesis workflow. Worms that carry the Mos1
transposon array oxEx229 and the Mos1 transposase array frEx113 in the CGL2-hypersensitive pmk-1(km25) background were generated.
doi:10.1371/journal.ppat.1000717.g003
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Figure 4. Results of the forward genetic screen for CGL2-resistant C. elegansmutants. (A) Resistance of isolated and constructed C. elegans
mutants towards CGL2-mediated toxicity. C. elegans mutants of the indicated genotypes were analysed for development from L1 to L4 as outlined
above. The gene appendix (op) and the bracket above the histogram indicate mutants isolated in the Mos1-screen. The other mutants were
constructed by crossing. The increase in the fractions of animals reaching L4 of the various mutants compared to N2 worms was statistically
significant (p,0.05). In case of the pmk-1 and the pmk-1;fut-1 mutant, not a single larva developed, so results were not compared statistically. (B)
Insertion sites of Mos1 elements in CGL2-resistant mutants. Arrows above Mos1 elements indicate the orientation of the Mos1 primer oJL115 used for
sequencing iPCR products of mutant lysates. Bold letters indicate C. elegans genomic sequences and are followed by Mos1 sequence. Gene models
are taken from WormBase Release WS207. bre-1(op509) mutants have a Mos1 insertion in the 59-UTR of C53B4.7a1, located 184 bp upstream of the
translational start codon. ger-1(op499) mutants have a Mos1 insertion in the first exon of R01H2.5, located 50 bp downstream of the translational start
codon. gly-13(op507) mutants have a Mos1 insertion in a conserved splicing donor site flanking the first exon of B0416.6. fut-8(op498) mutants have a
Mos1 insertion in the eighth exon of C10F3.6. galt-1(op497) mutants have a Mos1 insertion in the second exon of M03F8.4.
doi:10.1371/journal.ppat.1000717.g004
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morphology but is not involved in glycosylation [39]. Thus, all of
the identified genes conferring CGL2-resistance, with the
exception of the previously uncharacterized gene M03F8.4,
suggested a specific role of a1,6-linked fucosylation at the
asparagine-linked GlcNAc of C. elegans N-glycans in CGL2-
mediated nematotoxicity.
To confirm these data and localize the target glycoconjugate of
CGL2 in situ, L1 larvae of pmk-1 and pmk-1;fut-8(op498) animals
were incubated for 24 h in a solution containing tetramethylrho-
damine(TAMRA)-labeled CGL2, transferred to plates seeded with
standard OP50 bacteria and examined by fluorescence microsco-
py thereafter. The pictures revealed a distinct red fluorescent
signal on the intestinal epithelium of pmk-1 but not of pmk-1;fut-
8(op498) animals suggesting that core a1,6-fucosylated N-glycans
are the in vivo ligands of CGL2 and that this glycoepitope
recognized by CGL2 localizes mainly to the intestinal epithelium
of C. elegans (Supplementary Table S1; Fig. 6).
Identified M03F8.4 mutants are defective in galactose
capping of a1,6-core fucose in C. elegans N-glycans
Based on these results, the specificity of CGL2 for b-galactosides
and the reported capping of core a1,6-fucose on C. elegans N-
glycans with galactose residues in b1,4-configuration [40], we
hypothesized that binding of CGL2 to this Galb1,4Fuca1,6
epitope was required for its nematotoxicity. We surmised that the
product of the M03F8.4 gene, which encodes a putative type II
membrane protein with a predicted glycosyltransferase GT-A
domain [41] may be, directly or indirectly, involved in the
biosynthesis of this N-glycan core modification. In order to
validate this hypothesis, the N-glycomes of the pmk-1 single mutant
Figure 5. CGL2-sensitivity test and biosynthetic context of available C. elegans fucosyltransferase and GlcNAc-transferase mutants.
(A) CGL2-sensitivity test. C. elegans mutants of the indicated genotypes were analysed for development from L1 to L4 as outlined above. The
differences between the L4 fractions of the fut-4(gk111) and dpy-6(e14);gly-13(ok712) mutants to N2 are statistically significant (p,0.01) in contrast to
the differences between the L4 fractions of the fut8(ok2558), gly-12(is47) and gly-14(id48) mutants to N2 (p,0.9). The differences of the residual
mutants to N2 could not be evaluated due to the lack of variance. (B) Biosynthetic context. The putative pathway for biosynthesis of the CGL2
epitope, based on previous in vivo and in vitro data, indicates the key roles of the enzymes encoded by the gly-13, fut-8 and galt-1(M03F8.4) genes; on
the other hand, FUT-1 acts after the processing by hexosaminidases such as HEX-2. Other fucosyltransferases such as FUT-2 through to FUT-6 are not
involved in modification of the reducing-terminal GlcNAc residue of N-glycans, whereas the gly-2 and gly-20 encoded enzymes are not prerequisites
for a1,6-fucosylation by FUT-8. Further modifications by other enzymes, encoded by unknown genes, are possible and result in structures such as the
depicted Hex5dHex2HexNAc2 glycan.
doi:10.1371/journal.ppat.1000717.g005
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and the identified CGL2-resistant pmk-1(km25);fut-8(op498) and
pmk-1(km25);M03F8.4(op497) double mutants were analysed. N-
glycans were released sequentially by PNGase F and PNGase A to
separate core a1,3-fucosylated structures from those devoid of this
epitope, labeled with 2-aminopyridine (PA) and analysed by
comparative two-dimensional HPLC combined with MALDI-
TOF mass spectrometric and enzymatic analysis of the individual
glycans. N-glycans of the analysed strains showed significant
differences in the normal phase 1st-dimension chromatograms
(Fig. 7, panel A). Among the PNGase F resistant N-glycans, i.e.
those bearing an a1,3 fucose at the reducing end GlcNAc, peaks
eluting at high retention times (tR = 40250 min) were strongly
reduced in the identified M03F8.4 mutant and were completely
absent in the identified fut-8 mutant; such a shift in NP-HPLC
chromatograms is consistent with a loss of higher molecular weight
glycans.
The individually obtained fractions were subsequently resolved in a
second dimension by reversed phase HPLC into pure glycans suitable
for structural characterization. The comparison of the 2nd dimension
chromatograms of 1st dimension fractions of equal retention times
revealed pronounced differences between the N-glycomes of the pmk-
1 strain and the two identified CGL2-resistant mutant strains also for
the region with less obvious differences in the 1st dimension
chromatograms (i.e., tR = 20240 min). For example, fractions at
tR = 34.0235.5 min in the 1
st dimension yielded comparable 2nd
dimension patterns (Fig. 7, panel B) with a highly abundant
sub-fraction (tR = 14.5 min) being only present in the pmk-1
pseudo wild type strain. MS analysis identified this peak as a
pyridylaminated glycan with the net composition Hex5dHex2Hex-
NAc2-2-amino-pyridine(PA) (m/z 1605). By MS/MS a daughter ion
at m/z 753 was observed, compatible with this glycan containing a
Figure 6. In situ localization of the glycoepitope recognized by
CGL2. C. elegans CGL2-sensitive pmk-1(km25) and CGL2-resistant pmk-
1(km25);fut-8(op498) worms were fed with TAMRA-labeled CGL2 and
examined by differential interference contrast (DIC) and red fluores-
cence (RF) microscopy. 32 and 25 animals, respectively, were scored for
staining of the intestinal epithelium (see Supplementary Table S1). The
numbers of worms with stained intestinal epithelium was significantly
different between the two genetic backgrounds (p,0.01).
doi:10.1371/journal.ppat.1000717.g006
Figure 7. Comparative analysis of the N-glycome in CGL2-
resistant C. elegans double mutants pmk-1;fut-8(op498) (red
trace) and pmk-1(km25);M03F8.4(op497) (green trace) and the
isogenic CGL2-hypersensitive single mutant strain pmk-1(km25)
(black trace). (A) and (B) HPLC of released and fluorescently labeled N-
glycans. Upon enzymatic release (here the PNGase F resistant, but
PNGase A sensitive glycome fraction is shown) and fluorescent labeling,
N-glycans were separated by normal phase HPLC and analysed by mass
spectrometry (A). Fractions at similar retention times (e.g., dashed
rectangle) were further separated by reversed phase HPLC and the
resulting pure glycans were analysed by mass spectrometry (MS) and
for selected fractions by MS/MS (B). (C) Structural characterization of a
selected isolated peak. Peak A found in the pmk-1 strain but not in the
two double mutant strains was treated with b1,4-galactosidase (b1,4-
Gal’ase) and a-fucosidase (a-Fuc’ase). The reaction products were
analysed by reversed phase HPLC and MS and MS/MS (see Supple-
mentary Figure S2). The blue HPLC trace represents the glycan standard
in glucose units (GU). Monosaccharides are represented as symbols:
Man (green circle), Gal (yellow circle), GlcNAc (blue square), Fuc (red
triangle), Hex (white circle).
doi:10.1371/journal.ppat.1000717.g007
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chitobiose core carrying a1,3- and a1,6-difucosylation at the reducing
end GlcNAc and an additional hexose linked to this reducing end
pyridylaminated trisaccharide.
The purified Hex5dHex2HexNAc2 PA-glycan was subsequently
treated with exoglycosidases and the reaction products were
further analysed by HPLC and MALDI-TOF MS and MS/MS
(Fig. 7, panel C). First, this saccharide was exposed to a-fucosidase
which prefers terminal a1,6 linked over a1,3 linked fucoses but no
shift in its HPLC elution characteristics was observed
(tR = 14.5 min) and the mass was unaltered as determined by
mass spectrometry. When this glycan was treated with a fungal
(Aspergillus) b1,4-specific galactosidase instead, a shift in retention
time was observed (tR = 12.5 min) and a loss of one hexose was
revealed by MS (m/z 1443) and assigned to the hexose linked to
the difucosylated reducing-terminal GlcNAc due to the absence of
the m/z 753 daughter ion in the reaction product. The
octasaccharide obtained (tR = 12.5 min) then proved sensitive
towards a-fucosidase and loss of the ‘decapped’ terminal a1,6-
linked fucose was observed (tR = 7.5 min, m/z 1297). These results
demonstrated the presence of a b1,4-linked galactose epitope on
the a1,6-linked fucose, a modification described previously by
Reinhold and co-workers [40]. Analysis of the complete set of 2D-
HPLC-MS-MS/MS data (Supplementary Figure S2) confirmed
the absence of the galactosylated fucose epitope in the identified
M03F8.4 mutant, suggesting that this gene encodes a glycosyl-
transferase that is required for the biosynthesis of the b1,4-
galactoside linked to the core a1,6- fucose residue. The
biochemical characterization of this enzyme, termed GALT-1, is
published elsewhere [42]. Based on the available evidence, a
pathway for the biosynthesis of Hex5dHex2HexNAc2 can be
proposed (Fig. 5, panel B).
Structural basis for the recognition of Galb1,4Fuc by
CGL2
In order to provide biochemical and structural evidence for the
interaction between CGL2 and this nematode-specific b-galacto-
side, the trisaccharide Galb1,4Fuca1,6GlcNAc was chemically
synthesized with a linker at the reducing end and used as ligand in
in vitro binding experiments with affinity-purified CGL2. Isother-
mal titration microcalorimetry measurements confirmed binding
of this trisaccharide to CGL2 and suggested a dissociation constant
of approximately 100 mM (Supplementary Figure S1). The
molecular basis of this interaction was investigated by determining
the X-ray structure of cocrystals between CGL2 and the
trisaccharide at 1.5 A˚ resolution (Fig. 8, panel A; Supplementary
Table S2). Comparisons with the previously determined structures
of complexes between CGL2 and the Thomsen-Friedenreich
antigen (Galb1,3GalNAc) and lactose (Galb1,4Glc) [28] revealed
that the structure of CGL2 as well as the direct hydrogen bonds
between CGL2 and the b-galactoside of the different carbohydrate
ligands were fully superimposable (Fig. 8, panel B). A major
difference between these structures lies in the orientation of the
preceding monosaccharide subunits to the protein, e.g. the plane
of Glc in lactose is perpendicular to the plane of Fuc in the
trisaccharide. Due to the low number of direct contacts, there
seems to exist a high degree of flexibility on the side of CGL2 with
regard to the identity of this monosaccharide subunit. The only
constraint is the orientation of the 39 (in glucose and fucose) or 49
(in GalNAc) OH of the linked monosaccharide to allow interaction
with the conserved carbohydrate-coordinating residues, Arg55 and
Glu75. In addition, these hydroxyl groups make additional contact
to Arg77 in case of Glc (in lactose) and Fuc (in Galb1,4Fu-
ca1,6GlcNAc) but not in case of GalNAc (in Thomsen-
Friedenreich antigen).
Discussion
Galectins are b-galactoside-binding lectins known primarily from
animals and fungi. In animals, galectins appear to have important
roles in development and immunity [43,44,45,46]. The function of
the fungal representatives of this lectin family, however, has
remained unclear. A role of fungal galectins in fruiting body
development, as suggested by their specific expression in these
reproductive structures [26] and the identification of a putative
endogenous ligand [47] could not be confirmed: Neither constitu-
tive expression nor silencing of the two C. cinerea isogalectins, CGL1
and CGL2, affected fruiting body formation [11]. These results
Figure 8. Detailed view of the interaction between CGL2 and Galb1,4Fuca1,6GlcNAc (A) and comparison with two other CGL2/
carbohydrate complexes (B). (A) Fourier difference map (with Fo - Fc coefficients) around the visible part of ligand contoured at 3 s. Residues
belonging to the binding pocket are displayed as sticks and H-bonds as dashed yellow lines. (B) Superimposition of the lactose (Galb1,4Glc) (green,
PDB ID 1ULC) and of the Thomsen-Friedenreich antigen (Galb1,3GalNAc) (blue, PDB ID 1ULG) onto the CGL2/Galb1,4Fuca1,6GlcNAc structure (yellow,
PDB ID 2WKK). The binding pocket is almost identical in all three structures.
doi:10.1371/journal.ppat.1000717.g008
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together with the toxicity of another mushroom galectin, Agrocybe
aegerita AAL, towards HeLa cells and mice [14,48] prompted us to
follow the hypothesis of a role of fungal galectins in the defense of
higher fungi against predators such as fungal-feeding nematodes. In
agreement with this hypothesis, we demonstrate that the C. cinerea
galectin CGL2 exhibited a pronounced toxicity towards the model
nematode C. elegans. The nematotoxic activity of CGL2 with a LD50
of 350 mg/ml was comparable to the entomotoxic activity of XCL,
a fruiting body lectin from another homobasidiomycete and of plant
lectins [13].
A role of fungal galectins in defense against predatory
nematodes is in line with their predicted cytoplasmic localization,
since fungal-feeding as well as plant-feeding nematodes feed by
adsorbing the cellular content using a mouth organ called stylet
that acts like a syringe [24]. In this light, the cytoplasm, which is
essentially free of complex glycoconjugates, is an ideal storage
compartment for lectins that are destined to find their ligands in
the intestine of predators [Comment: in this study, the anatomical
limitation of C. elegans, as regards a stylet, is circumvented by
expression of the recombinant lectin in the cytoplasm of bacteria].
Indeed, a growing number of cytoplasmic lectins has been
identified in plants, possibly complementing the classical vacuolar
lectins in the defense of plants against herbivores [49]. Since the
cytoplasmic localization is a hallmark of fruiting body lectins, we
are currently testing a whole series of such lectins for toxicity
towards various organisms including C. elegans to provide
additional experimental support for a role of these fungal lectins
in defense. A recent survey of insecticidal activities in fruiting
bodies suggests that most of these activities are protein-based and,
thus, that the protein-mediated defense may be at least as
significant for fungal physiology and ecology as the more
established chemical defense of fungi by secondary metabolites
[50,51,52].
The identified ligand of CGL2 in C. elegans, Galb1,4Fuca1,6
modification of the proximal GlcNAc of N-glycan cores, was
originally discovered as a feature of octopus and squid rhodopsin
[53,54] and keyhole limpet hemocyanin [55]. The physiological
significance of this N-glycan modification is unknown and the
identification of a novel, putative glycosyltransferase required for
this modification may shed light both on its distribution and
function. The biochemical characterization of the relevant C.
elegans enzyme is published elsewhere [42]. None of the mutations
affected in the biosynthesis of this specific glycoepitope showed
obvious defects in development under standard laboratory
conditions. In the light of the fact that these mutations were
identified, because they conferred resistance towards CGL2-
expressing E. coli, it is noteworthy that mutations in gly-12, gly-13
and gly-14, coding for the three GnTI isoenzymes of C. elegans,
were previously reported to affect the response of C. elegans to
pathogenic bacteria [39]. This could suggest that the Galb1,4Fu-
ca1,6GlcNAc epitope, or some other GnTI-dependent modifica-
tion, plays a specific role in the defense of C. elegans against
bacterial pathogens. The fact that, of these three mutations, only
gly-13 led to resistance against CGL2-expressing E. coli may reflect
the ubiquitous expression of this gene and the function of its
product as the major GnTI in C. elegans [36]. On the other hand,
even though the gly-14 gene was reported to be specifically
expressed in the intestine (i.e., the same tissue which we observe
expresses CGL2 epitopes), the lack of resistance shown by the gly-
14 mutant can be explained by the ‘overruling’, ubiquitous
expression of gly-13 [56]. As noted above, core a1,6-fucosylation
by the FUT-8 enzyme, required as the basis for subsequent
galactosylation by GALT-1, the M03F8.4 gene product, is itself
dependent on the prior action of GnTI. On the other hand,
GlcNAc transferases II and V (encoded by the gly-20 and gly-2
genes, respectively) are not prerequisites for the action of FUT-8
and, thus, the lack of resistance of gly-2 and gly-20 mutants to
CGL2 is not surprising. The other tested fucosyltransferase
mutants (fut-1 through to fut-6) affect other forms of fucosylation
and are not involved in the formation of the Galb1,4Fuca1,6
epitope.
Analysis of the C. elegans glycome suggests that there are, besides
the Galb1,4Fuca1,6GlcNAc epitope, additional b-galactosides on
N-glycans [37], on O-glycans [57] and on glycosphingolipids [5]
representing potential CGL2-ligands based on the carbohydrate-
binding specificity of this galectin [27]. However, the exclusive and
almost complete resistance of C. elegans mutants affected in the
biogenesis of the b1,4-galactoside on the a1,6-bound core fucose
of N-glycans and the almost full sensitivity of all other tested
mutants suggest that these other potential ligands are either not
accessible for CGL2, not bound by CGL2 or their binding by
CGL2 does not lead to toxicity. From the experiments with B.
thuringiensis Cry5B toxin [58] and our own experiments with
Thomsen-Friedenreich antigen (Galb1,3GalNAc)-binding fungal
lectins (S. Bleuler, unpublished), it can be concluded that at least
some of these additional b-galactoside-containing glycoconjugates
are present in the C. elegans intestine, making the first possibility
unlikely. Since mutations in the GDP-fucose biosynthetic pathway
still allowed formation of residual b-galactoside-containing glyco-
sphingolipids [59] but led to complete loss of CGL2-binding to the
intestinal epithelium (data not shown), we conclude that CGL2
does not bind these b-galactosides in vivo, at least not in sufficient
degree to be visualized. This explanation may also apply for
Thomsen-Friedenreich antigen, an epitope which is associated
with C. elegans O-glycans and was shown to bind CGL2 in vitro,
albeit with low affinity [28,47,57].
On the other hand, the sensitivity of the bre-mutants, except for
bre-1, towards CGL2, suggests that the resistance of these mutants
towards the B. thuringiensis crystal toxin Cry5B is highly specific
and that such resistances depend on the carbohydrate-binding
specificity of the respective lectin/toxin. This conclusion is further
validated by the sensitivity of some of the reported CGL2-resistant
mutants towards other nematoxic fruiting body lectins (S. Bleuler,
unpublished).
Analogous to our own results, the Galb1,4Fuca1,6GlcNAc
epitope was recently identified as a ligand for the endogenous C.
elegans galectin LEC-6 in vitro [60]. It is not known, however,
whether this interaction occurs also in vivo and what the
consequences of such an interaction would be. Similar to
mutations interfering with the formation of the glycoepitope (see
above), knockdown of lec-6 mRNA did not result in any obvious
phenotype in C. elegans high-throughput functional studies [61]. In
the light of the proposed role of the Galb1,4Fuca1,6GlcNAc
epitope in the response of C. elegans to pathogenic bacteria, it is
noteworthy that expression of the lec-6 gene was induced upon
exposure of C. elegans to Photorhabdus luminescens [62].
The molecular details of the interaction between CGL2 and
Galb1,4Fuca1,6GlcNAc and other characterized ligands suggest
that CGL2, and possibly many other galectins, have a relaxed
specificity in vitro with regard to the type of linkage and the type of
sugar attached to the galactose as long as the 39 (in glucose and
fucose) or 49 (in GalNAc) OH of the linked monosaccharide is in
the right orientation to interact with the conserved carbohydrate-
coordinating residues, Arg55 and Glu75; of the other residues
involved in binding, Arg77 only makes contact with Glc in lactose
and fucose in Galb1,4Fuca1,6GlcNAc but not with GalNAc in
Thomsen-Friedenreich antigen. Our isothermal titration micro-
calorimetry (ITC) data does not allow conclusive statements about
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the relative affinity of CGL2 to Galb1,4Fuca1,6GlcNAc vs. other
non-substituted, terminal b-galactosides but taking the structural
data into account, it can be estimated that the affinity to
Galb1,4Fuc is in the same range or even slightly higher than to
other ligands. In an in vivo context, the CGL2 epitope is part of a
larger N-glycan structure, which may indeed have a higher affinity
towards the lectin than the trisaccharide tested here. Analogously,
the role of an entire structure in optimal binding to N-glycans was
shown by studies on anti-HRP which recognises core a1,3-
fucosylated determinants [63]. Such a binding mode would help to
explain why there is apparently no biological significance to the in
vitro binding of CGL2 to the Thomsen-Friedenreich antigen (see
discussion above).
Apart from the identity of the target glycoconjugate, we can
only speculate about the mechanism of CGL2-mediated nemato-
toxicity: Based on the in situ localization of the glycoconjugate
using fluorescently labeled CGL2, we assume that the recognized
N-glycan is bound to one or several proteins on the epithelial
membrane or the peritrophic membrane of the intestine. The fact
that we isolated in our screen exclusively mutations in carbohy-
drate-active enzymes, suggests that toxicity is not based on the
interaction between CGL2 and a particular ‘‘receptor’’ N-
glycoprotein but is rather caused by binding of CGL2 to different
N-glycoproteins characterized by the Galb1,4Fuca1,6 epitope. A
recent proteomic approach identified a number of such glycopro-
teins based on recognition by LEC-6 [64]. The caveats of such a
conclusion are that our results are still compatible with a specific
‘‘receptor’’ N-glycoprotein for CGL2 and that the screen is
probably not saturated and, by design, not able to identify
mutations in genes that are essential for worm viability.
The intestinal localization of the CGL2-ligand in C. elegans
coincides with the morphological changes of the intestinal
epithelium upon feeding with CGL2-expressing E. coli. Similar
morphological changes were reported in C. elegans in response to
feeding with E. coli expressing the B. thuringiensis crystal toxin Cry5B
[29] and other toxin-producing, gram-positive and gram-negative
bacteria [65,66]. Enlargement of the intestinal lumen and damage
of microvillar structure of the epithelium was also observed in insect
larvae upon feeding with the entomotoxic mammalian galectin-1
and snow drop lectin (GNL), respectively [67,68]. The morpholog-
ical changes are usually more pronounced in the anterior part of the
intestine possibly because this part receives the highest concentra-
tion of the lectins/toxins upon feeding.
Preliminary experiments with purified CGL2 and HeLa cells
suggest that the lectin is cytotoxic, rapidly endocytosed and ends up
in a perinuclear compartment (M. Garbani, unpublished). This is in
contrast to the A. aegerita galectin (AAL) which is also toxic for HeLa
cells but enters the cytoplasm and nucleoplasm of the cells [48]. This
difference in behavior between two different fungal galectins might
be due to differences in oligomerization: AAL is a dimer whereas
CGL2 forms a tetramer in solution, which might restrict its access to
the cyto- and nucleoplasm [15,28]. The cytotoxicity of AAL was
recently shown to be dependent on a conserved hydrophobic patch
on the protein surface in addition to domains involved in
oligomerization and carbohydrate-binding [15]. At this point, we
do not know whether this patch is also required for CGL2-mediated
toxicity. Cytotoxicity towards mammalian cells is shared between
fungal and mammalian galectins. However, ligands and toxicity
mechanisms appear to vary between the different mammalian
galectins and cell types [69,70,71,72,73,74]. It remains to be tested,
whether CGL2 uses one of the ligands and toxicity mechanisms
identified for the mammalian galectins, whether endocytosis is
necessary for cytotoxicity and how these processes relate to the
nematotoxicity of CGL2.
Materials and Methods
Strains and cultivation conditions
Escherichia coli strains DH5a and BL21(DE3) were used for
cloning and amplification of plasmids and bacterial expression of
proteins, respectively. E. coli was cultivated on standard media as
described [75]. Caenorhabditis elegans strains were maintained on
nematode growth media (NGM) and fed with E. coli strain OP50 as
described [76]. The Bristol isolate N2 was used as the wild type
strain. Strains pmk-1(km25), sek-1(ag1), nsy-1(ag3), bre-1(ye4), bre-
2(ye31), bre-3(ye26), bre-4(ye27), bre-5(ye17), fut-1(ok892), fut-2(gk360),
fut-2(ok509), fut-3(gk103), fut-4(gk111), fut-5(ok242), fut-6(ok475), fut-
8(ok2558), gly-2(qa703), gly-12(is47), dpy-6(e14);gly-13(ok712), gly-
14(id48), gly-20(ok826), unc-119(ed3) were obtained from the
Caenorhabditis Genetics Center (CGC) at the University of
Minnesota (USA). The strain carrying the two extrachromosomal
constructs frEx113[hsp::MosTransposase;Pcol12::DsRed] and ox-
Ex229[Mos1;Pmyo-2::gfp] was kindly provided by Jonathan Ew-
bank. For Mos1-mediated mutagenesis, we generated the strains
pmk-1(km25);frEx113 and pmk-1(km25);oxEx229. Strains resulting
from Mos1-mediated mutagenesis and subsequent outcrossing
were pmk-1(km25); M03F8.4(op497), pmk-1(km25); fut-8(op498),
pmk-1(km25); ger-1(op499), pmk-1(km25);gly-13(op507) and pmk-1
(km25);bre-1(op509). Primers used for genotyping are listed in
Supplementary Table S3.
Cloning and expression
Plasmid pET24-CGL2 for expression of authentic CGL2 in
BL21(DE3) was described previously [27]. The plasmid for
bacterial expression of C. cinerea CGL2(W72G) was constructed
by amplifying the respective open reading frame from pYADE4-
CGL2(W72G) [28] using the primers NdeI-CGL2N and BamHI-
CGL2C [27] and ligating the resulting fragment into pET24a
(Invitrogen) using the introduced restriction sites. Plasmid pET24-
CGL1 for expression of authentic CGL1 in BL21(DE3) was
constructed analogously using cgl1-specific primers and plasmid
pBCG1 as template [26]. Expression of CGL2 and CGL2(W72G)
in liquid culture was performed as described for CGL3 [27]. For
the C. elegans bioassays, 300 ml of a overnight culture of the
respective BL21(DE3) transformants were spread on NGM-plates
containing 1 mM isopropyl-b-D-thiogalactoside (IPTG) and
50 mg/ml Kanamycin and incubated overnight at 23uC before
addition of the nematodes. Lectin expression was verified by
separating whole cell extracts of induced BL21(DE3)-transfor-
mants on Coomassie blue-stained SDS-polyacrylamide gels and
immunoblotting using anti-CGL2 antiserum [26] (data not
shown).
Protein purification and labeling
Bacterial cell pellets were resuspended in ice-cold phosphate-
buffered saline (PBS) [30 mM Na-phosphate pH 7.3, 150 mM
NaCl] containing 1 mM phenylmethylsulfonyl fluoride and
ruptured using a French press. Cell debris was removed in two
consecutive steps of centrifugation at 12000 g for 15 min and
27000 g for 30 min. The supernatant was incubated with lactosyl-
sepharose at 4uC for 1 h and CGL2 was finally eluted at room
temperature in PBS containing 200 mM lactose. After size
exclusion chromatography on Superose 6 10/300 GL (GE
Healthcare) equilibrated in PBS, fractions containing the protein
were pooled and concentrated using an Amicon Ultra-4
centrifugal filter device (Millipore) with a molecular weight cutoff
of 10 kDa. Protein concentration was calculated by measuring the
absorbance at 280 nm, assuming a relation of 1.25 mg/ml to 1
unit absorbance at 280 nm for a path length of 1 cm.
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Conjugation of purified CGL2 to tetramethylrhodamine
(TAMRA) (Molecular Probes) was performed as described
[47].
C. elegans toxicity assays
A plate assay was devised to examine the toxicity of authentic
CGL1 and CGL2 and mutant CGL2 towards C. elegans. NGM
plates were seeded with E. coli BL21(DE3) expressing either
authentic CGL1 or CGL2 or mutant CGL2(W72G) as described
above. As a control, plates were seeded with E. coli BL21(DE3)
containing the vector pET24a. The plates were incubated
overnight at 23uC and seeded with synchronized populations of
C. elegans [77] for the different toxicity assays:
Microscopic analysis. For microscopic analysis of the toxic
effect of CGL2 towards C. elegans, L4 animals were seeded onto the
plates and examined after 24 h at 23uC.
Developmental assay. Quantitative data on the effect of
CGL1 and CGL2 on C. elegans development was acquired by
placing 50 to 100 newly hatched L1 larvae of the indicated
genotypes on the plates. After 72 h, the fraction of animals that
reached L4 stage was determined.
Brood size assay. The effect of CGL2 on C. elegans
reproduction was assayed by picking individual L4 wild type
hermaphrodites onto plates. Thereafter, the mothers were
transferred to new plates daily until the mother either stopped
producing offspring or died. The progeny of the previous plate
were counted the next day. The number of progeny from the
various plates were added up to give the final brood size.
Determination of the CGL2 median lethal dose
(LD50). We defined the LD50 as the concentration of toxin at
which .50% of the animals fail to reach larval stage 4 (L4) within
96 h in liquid culture. 20 L1 staged C. elegans wild type worms were
placed in wells containing S-medium [78], E. coli BL21 containing
empty vector pET24a with a KanR gene as a food source,
kanamycin and chloramphenicol (30 mg/ml each) and purified
CGL2 protein in the concentrations indicated. After 96 h, the
worms were transferred to NGM plates and the number of worms
that reached L4 stage was determined.
Survival curves. For the comparison between CGL2-,
CGL2(W72G)-expressing and empty vector control-containing
bacteria (Fig. 1, panel C), 10 L4 stage wild type C. elegans (N2) were
seeded onto plates with the respective bacterial lawns. Surviving
animals were transferred each day onto a novel plate with the
same type of bacterial lawn. For the hypersensitivity assay (Fig. 3,
panel A), 10 L4 stage C. elegans of the indicated genotypes were
transferred to plates with CGL2-expressing bacteria. The plates
were checked for surviving animals every 24 h. A worm was
considered dead when it did not react to touching with a worm
pick.
Statistical analysis
The statistical significance of the results was evaluated using
appropriate tests. The results of the developmental toxicity assay
were analyzed by the non-parametric Kolmogorov-Smirnov test,
comparing pairwise each lectin to the vector control and each C.
elegans mutant to the wildtype strain. The differences in the brood-
size were compared, also pairwise, using a t test. For the statistical
evaluation of the survival curves a Kaplan-Meyer analysis in
combination with log rank tests was used. The difference in the
CGL2-TAMRA staining between two different C. elegans strains
was assessed using a chi square test of the respective numbers of
animals showing specific staining of the intestinal epithelium (see
Supplemental Table S1).
Screen for CGL2-resistant C. elegans mutants using Mos1
insertional mutagenesis
Mos1 insertional mutagenesis was in principle performed as
published [79]. We used the extrachromosomal arrays frEx113,
which carries the Mos1 transposase under the control of a heat-
shock promoter, and oxEx229, which carries multiple copies of the
substrate Mos1 transposon. The two extrachromosomal constructs
were crossed into CGL2-hypersensitive pmk-1(km25) worms to
generate the two starting strains pmk-1(km25);frEx113 and pmk-
1(km25);oEx229 for the screen. To generate double-array carrying
animals, pmk-1(km25);oxEx229 males were crossed to L4 pmk-
1(km25);frEx113 hermaphrodites. Progeny containing both arrays,
recognized by the concurrent expression of GFP in the pharynx
(Pmyo-2::gfp, contained in oxEx229) and DsRed in the epidermis
(Pcol12::DsRed, contained in frEx113), were propagated for approx-
imately six generations before subjecting them to heat-shock.
Several hundred double-transgenic animals per mutagenesis round
were subjected to heat-shock for 1 h at 33uC, 1 h at 20uC, and 1 h
at 33uC and then allowed to recover overnight at 20uC. P0 were
distributed to 90 mm NGM plates and eggs were collected
12–40 h after heat shock. P0 were then removed. After 3 days,
gravid F1 were washed off the plates in M9 buffer and F2 eggs were
isolated as described [76]. The synchronized population of F2 L1
animals was distributed on 30 plates containing CGL2-expressing
E. coli BL21(DE3). After 3 to 7 days, these plates were screened for
CGL2-resistant animals that had reached adulthood. Each plate
with resistant animals was treated as an individual hit to avoid
redundant Mos1 insertions. Candidate worms were propagated on
CGL2-expressing E. coli to confirm the resistance phenotype.
Once resistance was confirmed, mutants that had lost the
extrachromosomal Mos1-bearing array were outcrossed 2 to 6
times before assaying for the presence of Mos1 elements and trying
to locate the site of insertion. For those mutants that still contained
a Mos1 element, we determined the insertion site through inverse
PCR on worm lysates as published [79].
In total, approximately 5009000 haploid genomes were screened.
The transposition efficiency was meassured as 50%. In total, 14
CGL2-resistant worms were isolated. Only 5 of them, pmk-1
(km25);M03F8.4(op497), pmk-1(km25);fut-8(op498), ger-1(op499); pmk-1
(km25), pmk-1(km25);gly-13(op507) and pmk-1(km25);bre-1(op509), con-
tained the Mos1 transposon insertion.
Light microscopy of C. elegans
For general worm handling, a Leica MZ 12.5 stereomicroscope
was used. To select double-array carrying worms (pmk-1(km25);ox-
Ex229;frEx113), we used a Leica MZ 16 FA stereomicroscope
equipped with appropriate filtersets (DsRed and GFP filter).
Pictures were taken with a Nikon Coolpix 990 digital camera.
For DIC and fluorescence microscopy, worms were placed
on 2% agarose pads in M9 [75], anaesthesized with levamisole
(3–5 mM) (Sigma) and mounted under a coverslip for observation
using a Leica DM-RA or Zeiss Axiovert 200 microscope equipped
with DIC (Nomarski) optics and standard epifluorescence with a
DsRed filterset for detection of TAMRA. Pictures were taken with
a Hamamatsu ORCA-ER camera. Images were false-coloured
using OpenLab software.
For the in situ localization of the CGL2-ligand, L4 staged C.
elegans were placed in wells containing S-medium [78], BL21(DE3)
E. coli harbouring empty KanR-vector, kanamycin and chloram-
phenicol at 30 mg/ml each and TAMRA-labeled CGL2 at
100 mg/ml. After 24 hrs, worms were transferred to standard
OP50 plates and screened for TAMRA fluorescence 2 h
thereafter.
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Electron microscopy of C. elegans
For electron microscopic examination, worms were prepared by
a described two-step chemical fixation [80]. Fixation and slicing of
the samples was kindly carried out by Garry Barmettler at the
Center for Microscopy and Image Analysis (University of Zurich,
Switzerland). The samples were examined using a Philips CM100
transmission electron microscope equipped with a side mounted
digital camera (Gatan).
Isolation of C. elegans N-glycans
C. elegans strains pmk-1(km25), pmk-1(km25);M03F8.4(op497) and
pmk-1(km25);fut-8(op498) were grown for 5 days at room temper-
ature in liquid culture with E. coli OP50 and afterwards separated
from bacteria and debris by 30% (w/v) sucrose gradient
centrifugation [76]. N-glycan preparation was performed as
previously published [81] by enzymatic release of glycans from
partially purified glycopeptides using peptide-N-glycanase
(PNGase) F and subsequently PNGase A in order to separate
core a1,3-fucosylated glycans from other core fucosylated glycans.
Briefly, approximately 3 g of worms (wet weight) were boiled prior
to grinding. The extract was adjusted to contain 5% (v/v) formic
acid and incubated with 3 mg pepsin (Sigma) at 37uC overnight.
After centrifugation at 159000 g for 15 min, the supernatant was
applied to 15 ml Dowex AG WX2 equilibrated with 2% acetic
acid. The glycopeptides were eluted with ammonium acetate (0.6
M, pH 6). Orcinol-positive fractions were pooled and lyophilized
overnight. The samples were then desalted by application to a
Sephadex G25 column and eluted with 1% acetic acid. The
orcinol-positive fractions were again pooled and lyophilized. The
samples were dissolved in 250 ml water. After heat treatment at
95uC for 5 min to inactivate residual pepsin, the samples were
cooled prior to addition of 250 ml ammonium carbonate buffer
pH 8 and 3 U PNGase F (Roche) and incubated overnight at
37uC. The samples were then acidified with 400 ml 10% acetic
acid and applied to 5 ml Dowex AG WX2. The unretained free
glycans were lyophilized and dried for subsequent fluorescent
labeling whereas the retained Orcinol positive fractions eluting
with ammonium acetate (0.6 M, pH 6) were desalted as above,
dissolved in ammonium acetate buffer (50 mM, pH 5) and treated
with PNGase A (0.6 mU) overnight at 37uC. Again the samples
were acidified with 400 ml 10% acetic acid and applied to 5 ml
Dowex AG WX2. The unretained free glycans were lyophilized
and also dried for subsequent fluorescent labeling.
Labeling and structural analysis of C. elegans N-glycans
Fluorescent labeling of the N-glycans was performed as
previously described using 2-amino-pyridine (PA). Complete N-
glycomes of either PNGase A or F released and pyridylaminated
glycans were fractionated by 2D-HPLC using a Shimadzu HPLC
system (consisting of a SCL-10A controller, two LC10AP pumps
and a RF-10AXL fluorescence detector controlled by a personal
computer using Class-VP software (V6.13SP2)) at room temper-
ature and fluorescence detection (excitation at 310 or 320 nm,
emission detected at 380 or 400 nm). The N-glycans were first
fractionated on a normal phase HPLC (Tosoh TSK gel Amide-80,
4.66250 mm, 5 mm; flow 1 ml/min, elution: 5 min isocratic
71.3% MeCN, 10 min gradient from 71.3% to 61.8% MeCN,
25 min isocratic 61.8% MeCN, 15 min 61.8% to 54.2% MeCN
using ammonium formate (10 mM, pH 7) as buffer). The fractions
were lyophilized and further fractionated on reversed phase HPLC
(Hypersil ODS C-18; 46250 mm, 5 mm; flow 1.5 ml/min,
gradient of 0–9% MeOH over 30 min using ammonium formate
(0.1 M, pH 4) as buffer). HPLC chromatograms were visualized
using the opensource program PLOT (Version 0.997 by
Wesemann and Thijsse). Each fraction was subjected to
monoisotopic MALDI-TOF MS using a Bruker Ultraflex TOF/
TOF with 2,5-dihydroxybenzoic acid as matrix. In general,
all fractions with fucose containing N-glycans were subjected to
MS/MS to elucidate their composition. A peptide standard
mixture (Bruker) was used for external calibration. MS data were
analysed using Bruker software and the mMass V2.4 software
package [82].
Selected isolated N-glycans were examined for the presence of
either terminal b-galactosides by treatment with Aspergillus oryzae
b1,4-galactosidase (27 mU, 50 mM sodium citrate, pH 4.5) [83]
for 2 days at 37uC or terminal a-fucosides by use of bovine kidney
a-fucosidase (Sigma, 15 mU, 50 mM ammonium acetate, pH 5).
Digestion products were subsequently analysed for altered
structural characteristics by RP-HPLC (see above) and MALDI-
TOF MS.
Chemical synthesis of Galb1,4Fuca1,
6GlcNAcbOC5H10NH2
See Supplementary Figure S3 and Supplementary Text S1.
Crystallization of CGL2 in complex with carbohydrate
ligand
Crystallization conditions were screened using the PEG/Ion
Screen from Hampton Research with the hanging-drop vapor-
diffusion method at 18uC. The best crystals were obtained by
mixing 2.5 ml of protein solution (10 mg/ml) containing 1 mM
Galb1,4Fuca1,6GlcNAcbOC5H10NH2 with 2.5 ml mother liquor
consisting of 0.2 M magnesium acetate, 20% (w/v) PEG 3350.
Drops were equilibrated against 500 ml reservoir solution. After 3
weeks, crystals were cryostabilized in mother liquor supplemented
with 25% glycerol and flash frozen in liquid nitrogen.
Data collection and structure determination
Diffraction data were collected at the Swiss Light Source,
beamline X06DA (Villigen, Switzerland) at 100 K and processed
with XDS, XSCALE and XDSCONV [84]. The structure was
readily solved by molecular replacement with MOLREP [85],
using the known CGL2 structure as a search model PDB ID 1UL9
[28]. The structure was refined anisotropically with Phenix [86] to
1.5 A˚ resolution and iterative model rebuilding was performed
using Coot [87]. Model statistics were obtained with Procheck/
Sfcheck as part of the CCP4 suite [85]. Molecular visualizations
and structures illustrations were performed using PyMOL [88].
Data processing and refinement statistics are summarized in
Supplementary Table S2. Coordinate and structure factors have
been deposited with the PDB under code 2WKK.
Supporting Information
Text S1 Chemical synthesis of Galb1,4Fuca1,6GlcNAc-
bOC5H10NH2 (Numbering of compounds refers to Supplemen-
tary Figure S3).
Found at: doi:10.1371/journal.ppat.1000717.s001 (0.06 MB
DOC)
Table S1 Statistics on CGL2-TAMRA staining (Fig. 6). Animals
were scored for specific staining of the intestinal epithelium.
Found at: doi:10.1371/journal.ppat.1000717.s002 (0.01 MB PDF)
Table S2 Statistics on data collection and refinement.
Found at: doi:10.1371/journal.ppat.1000717.s003 (0.05 MB PDF)
Table S3 Primers used in this study.
Found at: doi:10.1371/journal.ppat.1000717.s004 (0.01 MB PDF)
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Figure S1 Isothermal calorimetry titration curve of CGL2 with
Galb1,4Fuca1,6GlcNAcbOC5H10NH2. The raw data is shown in
the upper panel. Transformation of the data using the Microcal
software yields the titration curve (lower panel), from which the
thermodynamic parameters were calulated.
Found at: doi:10.1371/journal.ppat.1000717.s005 (0.14 MB PDF)
Figure S2 Mass spectrometric analysis of the Hex5dHex2Hex-
NAc2 glycan. The isolated fraction containing the Hex5dHex2-
HexNAc2 N-glycan as well as aliquots of this glycan treated with
either fucosidase alone, galactosidase alone or sequentially with
galactosidase and fucosidase were analysed by MALDI-TOF MS;
the spectra are annotated with the m/z values for the [M+Na]+
species (left). The corresponding MALDI-TOF MS/MS fragmen-
tation spectra are also shown and annotated with the putative
structures of key diagnostic fragments (right).
Found at: doi:10.1371/journal.ppat.1000717.s006 (0.05 MB PDF)
Figure S3 The synthesis of Galb1,4Fuca1,6GlcNAcbOC5H10NH2.
Reaction conditions: a) AcOH, 50uC; b) Bu2SnO, toluene,
reflux; c) BnBr, TBAI, 40uC; d) FmocCl, pyridine; e) K2CO3,
Cl3CCN, DCM; f) N-(benzyl)-benzyloxycarbonyl-5-aminopentan-
1-ol, TMSOTf, DCM, -15uC; g) HF-pyridine, THF; h) 4, DMTST,
DTBMP, DCM, -10uC; i) Et3N; j) 2,3,4,6-tetra-O-benzoyl-b-D-
galactopyranosyl trichloroacetimidate, TMSOTf, DCM, -10uC; k)
ethylenediamine, nBuOH, reflux; l) Ac2O, pyridine; m) NaOMe,
MeOH; n) Pd/C, H2, MeOH/H2O/AcOH.
Found at: doi:10.1371/journal.ppat.1000717.s007 (0.12 MB PDF)
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